HEALTH CATALYST INC (HCAT) Stock Analyst Earnings Estimates
NASDAQ:HCAT - Nasdaq - US42225T1079 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 276.2M 14.18% | 295.938M 7.15% | 306.584M 3.60% | 340.96M 11.21% | 372.07M 9.12% | 410.41M 10.30% | 481.2M 17.25% | |
| EBITDA YoY % growth | -86.8M -10.90% | -44.735M 48.46% | -14.023M 68.65% | 41.38M 395.09% | 52.373M 26.57% | 65.67M 25.39% | 79.552M 21.14% | |
| EBIT YoY % growth | -135.1M -16.67% | -86.958M 35.63% | -55.454M 36.23% | -47.762M 13.87% | -31.34M 34.38% | -8.79M 71.95% | -18.461M -110.01% | |
| Operating Margin | -48.91% | -29.38% | -18.09% | -14.01% | -8.42% | -2.14% | -3.84% | |
| EPS YoY % growth | -0.27 37.21% | 0.15 155.56% | 0.28 86.67% | 0.24 -12.94% | 0.38 57.59% | 0.65 67.93% | 0.77 18.58% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.07 2.82% | 0.12 194.37% | 0.08 730.59% | 0.13 231.50% | 0.14 91.33% | 0.15 25.61% |
| Revenue Q2Q % growth | 82.473M 8.02% | 84.903M 6.65% | 89.833M 13.12% | 95.046M 17.75% | 96.204M 16.65% | 100.09M 17.89% |
| EBITDA Q2Q % growth | 11.149M -41.21% | 15.133M -46.46% | 11.433M 1,004.51% | 13.23M -0.83% | 12.426M 11.45% | 13.918M -8.03% |
| EBIT Q2Q % growth | -8.107M 33.55% | -4.38M 66.74% | -8.081M 40.51% | -7.077M 39.32% | -7.001M 13.64% | -6.398M -46.07% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.04 -66.67% | 0.03 | 0.01 | 15.68% |
| Q1 2025 Q2Q % growth | 0.01 -80.00% | 0.00 | 0.01 | 390.20% |
| Q4 2024 Q2Q % growth | 0.04 100.00% | 0.08 | -0.04 | -46.95% |
| Q3 2024 Q2Q % growth | 0.07 133.33% | 0.10 | -0.03 | -29.75% |
| Q2 2024 Q2Q % growth | 0.12 140.00% | 0.08 | 0.04 | 48.34% |
| Q1 2024 Q2Q % growth | 0.05 | 0.03 | 0.02 | 75.51% |
| Q4 2023 Q2Q % growth | 0.02 140.00% | 0.00 | 0.02 | 2,661.67% |
| Q3 2023 Q2Q % growth | 0.03 123.08% | -0.02 | 0.05 | 272.20% |
| Q2 2023 Q2Q % growth | 0.05 266.67% | 0.00 | 0.05 | 1,421.28% |
| Q1 2023 Q2Q % growth | 0.05 183.33% | -0.04 | 0.09 | 220.47% |
| Q4 2022 Q2Q % growth | -0.05 73.68% | -0.12 | 0.07 | 56.62% |
| Q3 2022 Q2Q % growth | -0.13 27.78% | -0.20 | 0.07 | 34.12% |
| Q2 2022 Q2Q % growth | -0.03 | -0.10 | 0.07 | 70.83% |
| Q1 2022 Q2Q % growth | -0.06 | -0.12 | 0.06 | 48.65% |
| Q4 2021 Q2Q % growth | -0.19 -18.75% | -0.22 | 0.03 | 12.01% |
| Q3 2021 Q2Q % growth | -0.18 14.29% | -0.22 | 0.04 | 18.81% |
| Q2 2021 Q2Q % growth | 0.00 100.00% | -0.14 | 0.14 | 100.00% |
| Q1 2021 Q2Q % growth | -0.06 62.50% | -0.15 | 0.09 | 60.03% |
| Q4 2020 Q2Q % growth | -0.16 23.81% | -0.20 | 0.04 | 18.72% |
| Q3 2020 Q2Q % growth | -0.21 22.22% | -0.27 | 0.06 | 23.40% |
| Q2 2020 Q2Q % growth | -0.15 28.57% | -0.23 | 0.08 | 34.05% |
| Q1 2020 Q2Q % growth | -0.16 | -0.26 | 0.10 | 38.08% |
| Q4 2019 Q2Q % growth | -0.21 | -0.30 | 0.09 | 29.01% |
| Q3 2019 Q2Q % growth | -0.27 | -0.38 | 0.11 | 28.46% |
| Q2 2019 Q2Q % growth | -0.21 | -0.31 | 0.10 | 32.50% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 80.721M 6.35% | 82.22M | -1.499M | -1.82% |
| Q1 2025 Q2Q % growth | 79.413M 6.28% | 80.752M | -1.339M | -1.66% |
| Q4 2024 Q2Q % growth | 79.606M 6.02% | 81.261M | -1.655M | -2.04% |
| Q3 2024 Q2Q % growth | 76.353M 3.50% | 77.827M | -1.474M | -1.89% |
| Q2 2024 Q2Q % growth | 75.902M 3.67% | 76.505M | -603K | -0.79% |
| Q1 2024 Q2Q % growth | 74.723M 1.16% | 76.298M | -1.575M | -2.06% |
| Q4 2023 Q2Q % growth | 75.084M 8.57% | 75.076M | 8K | 0.01% |
| Q3 2023 Q2Q % growth | 73.773M 7.93% | 74.117M | -344K | -0.46% |
| Q2 2023 Q2Q % growth | 73.213M 3.66% | 74.087M | -874K | -1.18% |
| Q1 2023 Q2Q % growth | 73.868M 8.49% | 72.669M | 1.199M | 1.65% |
| Q4 2022 Q2Q % growth | 69.16M 6.86% | 69.621M | -461K | -0.66% |
| Q3 2022 Q2Q % growth | 68.35M 10.71% | 68.13M | 220K | 0.32% |
| Q2 2022 Q2Q % growth | 70.63M 18.45% | 71.265M | -635K | -0.89% |
| Q1 2022 Q2Q % growth | 68.09M 21.92% | 67.345M | 745K | 1.11% |
| Q4 2021 Q2Q % growth | 64.72M 21.47% | 64.408M | 312K | 0.48% |
| Q3 2021 Q2Q % growth | 61.74M 30.83% | 62.025M | -285K | -0.46% |
| Q2 2021 Q2Q % growth | 59.63M 37.84% | 57.908M | 1.722M | 2.97% |
| Q1 2021 Q2Q % growth | 55.85M 23.78% | 55.506M | 344K | 0.62% |
| Q4 2020 Q2Q % growth | 53.28M 22.48% | 53.163M | 117K | 0.22% |
| Q3 2020 Q2Q % growth | 47.19M 19.71% | 45.485M | 1.705M | 3.75% |
| Q2 2020 Q2Q % growth | 43.26M 17.55% | 42.98M | 280K | 0.65% |
| Q1 2020 Q2Q % growth | 45.12M 28.15% | 44.339M | 781K | 1.76% |
| Q4 2019 Q2Q % growth | 43.5M | 42.54M | 960K | 2.26% |
| Q3 2019 Q2Q % growth | 39.42M | 38.469M | 951K | 2.47% |
| Q2 2019 Q2Q % growth | 36.8M | 37.208M | -408K | -1.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -8.95% | -18.66% | 0% | -18.76% |
| Revenue | -4.72% | -4.5% | 0.09% | 0.01% |